首页|铁死亡抑制剂在6-羟基多巴胺诱导帕金森病模型大鼠中的应用价值

铁死亡抑制剂在6-羟基多巴胺诱导帕金森病模型大鼠中的应用价值

扫码查看
目的 探讨铁死亡抑制剂在6-羟基多巴胺(6-OHDA)诱导帕金森病(PD)模型大鼠中的应用价值.方法 16只成年雄性SD大鼠适应性喂养1周后进行造模,造模成功的PD模型大鼠随机分为PD组、铁死亡抑制剂组,各8只.铁死亡抑制剂组给予2 mg/kg ferrostatin-1腹腔注射,PD组给予等剂量生理盐水腹腔注射,连续14 d.最后1次给药后24 h进行大鼠行为学检测,记录健侧旋转的圈数、逃避潜伏期、穿越平台次数.颈椎脱臼处死大鼠后取适量脑黑质组织,测定PD相关蛋白谷胱甘肽过氧化物酶4(GPX4)、溶质载体家族7成员11(SLC7A11)表达水平、氧化应激[活性氧(ROS)、谷胱甘肽(GSH)、脂质过氧化物(LPO)、丙二醛(MDA)]及炎症指标水平[肿瘤坏死因子-α(TNF-α)、白细胞介素(IL)-1β、IL-6].结果 PD组健侧旋转的圈数、逃避潜伏期、穿越平台次数分别为(120.31±28.50)圈、(41.72±6.59)s、(2.76±0.45)次,铁死亡抑制剂组分别为(78.63±11.23)圈、(24.98±5.40)s、(4.09±0.56)次.铁死亡抑制剂组大鼠的健侧旋转的圈数较PD组少,逃避潜伏期较PD组短,穿越平台次数较PD组多(P<0.05).铁死亡抑制剂组大鼠的脑黑质组织中GPX4、SLC7A11蛋白表达量分别为(2.96±0.51)、(2.25±0.35),均高于PD组的(2.18±0.42)、(1.76±0.20)(P<0.05).铁死亡抑制剂组大鼠的脑黑质组织匀浆中ROS、LPO、MDA水平分别为(4.08±0.47)pg/ml、(6.54±1.09)μg/ml、(3.26±0.42)ng/ml,低于PD组的(5.21±0.67)pg/ml、(8.35±1.20)μg/ml、(4.10±0.56)ng/ml,GSH水平(13.24±2.89)ng/ml高于PD组的(10.18±2.30)ng/ml(P<0.05).铁死亡抑制剂组大鼠的脑黑质组织匀浆中TNF-α、IL-1β、IL-6水平分别为(14.22±1.98)、(16.29±2.75)、(6.42±0.97)pg/ml,低于PD组的(18.29±2.65)、(23.01±4.39)、(8.36±1.10)pg/ml(P<0.05).结论 铁死亡抑制剂可减轻6-OHDA诱导PD模型大鼠的行为学异常,主要与其上调抗氧化蛋白表达、抑制氧化应激及炎症反应的作用相关.
Practical value of ferroptosis inhibitor in a rat model of 6-hydroxydopamine-induced Parkinson's disease
Objective To explore the practical value of ferroptosis inhibitor in a rat model of 6-hydroxydopamine (6-OHDA)-induced Parkinson's disease (PD). Methods 16 a dult male SD rats were modulated after 1 week of adaptive feeding. PD model rats successfully modulated were randomly divided into PD group and ferroptosis inhibitor group,with 8 rats in each group. Ferroptosis inhibitor group was given 2 mg/kg ferrostatin-1 intraperitoneal injection,PD group was given equal dose of normal saline intraperitoneal injection for 14 consecutive days. Behavioral tests were performed 24 h after the last dose,and the number of healthy side rotation,escape latency and number of crossing the platform were recorded. Proper amounts of substantia nigra tissue were taken from rats after cervical dislocation execution,and the expression levels of PD-associated protein glutathione peroxidase 4 (GPX4),solute carrier family 7,member 11 (SLC7A11),oxidative stress[reactive oxygen species (ROS),glutathione (GSH),lipid peroxides (LPO),malondialdehyde (MDA)]and inflammatory markers[tumor necrosis factor-α (TNF-α),interleukin (IL)-1β,IL-6]were determined. Results The number of healthy side rotation,escape latency and number of crossing the platform of PD group were (120.31±28.50) turns,(41.72±6.59) s and (2.76±0.45) times,while those of ferroptosis inhibitor group were (78.63±11.23) turns,(24.98±5.40) s and (4.09±0.56) times. Compared with PD group,the number of healthy side rotation of rats in ferroptosis inhibitor group was reduced,the escape latency was shortened,and the number of crossing the platform was increased (P<0.05). The expression levels of GPX4 and SLC7A11 in the substantia nigra of ferroptosis inhibitor group were (2.96±0.51) and (2.25±0.35),which were higher than (2.18±0.42) and (1.76±0.20) of PD group (P<0.05). The levels of ROS,LPO,and MDA in the substantia nigra tissue homogenate of ferroptosis inhibitor group were (4.08±0.47) pg/ml,(6.54±1.09) μg/ml,and (3.26±0.42) ng/ml,which were lower than (5.21±0.67) pg/ml,(8.35±1.20) μg/ml,and (4.10±0.56) ng/ml of PD group;GSH level of ferroptosis inhibitor group was (13.24±2.89) ng/ml,which was higher than (10.18±2.30) ng/ml of PD group (P<0.05). The levels of TNF-α,IL-1β and IL-6 in the substantia nigra tissue homogenate of ferroptosis inhibitor group were (14.22±1.98),(16.29±2.75) and (6.42±0.97) pg/ml,which were lower than (18.29±2.65),(23.01±4.39) and (8.36±1.10) pg/ml of PD group (P<0.05). Conclusion Ferroptosis inhibitor can alleviate behavioral abnormalities in PD model rats induced by 6-OHDA,which is mainly related to its up-regulation of antioxidant protein expression,inhibition of oxidative stress and inflammation.

Parkinson's disease6-hydroxydopamineFerroptosis inhibitorBehavioral scienceOxidative stressInflammation

木其尔、许舒婷、闫红贺、卑红喆

展开 >

014040 内蒙古科技大学包头医学院

014010 内蒙古包钢医院神经内科

476200 柘城县人民医院神经内科

帕金森病 6-羟基多巴胺 铁死亡抑制剂 行为学 氧化应激 炎症反应

2024

中国实用医药
中国康复医学会

中国实用医药

影响因子:0.797
ISSN:1673-7555
年,卷(期):2024.19(23)